Clinical Trial Update: Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hypofractionated chemoradiotherapy with Thymosin α1 for unresectable or recurrent thymic epithelial tumors (thymoma and thymic carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymoma

Drugs mentioned

• Thymosin α-1 (thymosin alpha-1)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Thymoma and Thymic Carcinoma | Phase 2 | Status: UNKNOWN